Subsequently, the IPA also predicted that combined TNKSi/MEKi treatment induced several stress response pathways in HCT-15 cells, including “NRF2 mediated oxidative stress response” (Figure 4 and Figure 5 and Figure S7), which has been linked to resistance to oxidants and to promote aggressive proliferation of cancer cells [50]. Here, NFE2L2 is linked to cancer.